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Peptide–membrane interactionspectroscopy performed on surface-supported bilayer membranes allows for the
monitoring of changes in membrane properties, such as thickness, ion permeability, and homogeneity, after
exposure to antimicrobial peptides (AMPs). We show that two model cationic peptides, very similar in
sequence but different in activity, induce dramatically different changes in membrane properties as probed
by impedance spectroscopy. Moreover, the impedance results excluded the “barrel-stave” and the “toroidal
pore”models of AMP mode of action, and are more consistent with the “carpet” and the “detergent”models.
The impedance data provide important new insights about the kinetics and the scale of the peptide action
which currently are not addressed by the “carpet” and the “detergent” models. The method presented not
only provides additional information about the mode of action of a particular AMP, but offers a means of
characterizing AMP activity in reproducible, well-deﬁned quantitative terms.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Membrane-disrupting peptides and proteins play important
biological roles ranging from the innate immune response to the
activity of toxins and venoms, and have many potential biotechnolo-
gical applications in areas including antimicrobial treatment and drug
delivery. A detailed understanding of their mechanism of action is
crucial. Currently, there are at least four different commonly used
models describing possible AMP modes of action: the barrel-stave
pore model, the toroidal pore model, the carpet model, and the
detergent-like membrane disruption model [1-5]. With the probable
exception of the barrel-stave pore model, there is neither agreement
on the hypothetical mechanisms described by each model, nor clear
distinction between these mechanisms. For example, Shai [1]
describes the carpet model as formation of small peptide–lipid
aggregates/bicelles, which resembles the detergent model [2]. Sato
and Feix [4] also do not distinguish between the carpet model and the
detergent model and comment that in some instances it is difﬁcult to
distinguish between carpet and toroidal pore mechanism. In addition,
many membrane-active peptides have detergent-like action at high
concentrations, independent of their mechanism of action at lower
concentrations.Charles Street, Baltimore, MD
ll rights reserved.The high-resolution structures of peptides that act according to
the barrel-stave model have answered many questions pertaining to
their activity [6]. The vast majority of antimicrobial peptides,
however, do not follow the barrel-stave model, and questions remain
as to which model correctly describes their activity. These questions
often speciﬁcally focus on explaining the transient nature of peptide-
induced permeabilization of membrane vesicles [7–12]. This is in part
because experimental observations of mechanism are indirect and
inconclusive due to the difﬁculty of following transient processes on
a molecular level. Existing experimental methods such as vesicle
interaction/leakage assays [7–12] or bacterial sterilization [13–17] are
limited to properties of the whole ensemble of peptides. Structural
measurements [18–20] are often performed after peptide–membrane
interaction and membrane permeabilization has already taken place,
instead of during the transient processes. Although all of these
methods yield valuable information about peptide activity, they
provide an incomplete picture of the detailed mechanism of AMP
mode of action. The purpose of this work is to use electrochemical
impedance spectroscopy (EIS) as a new experimental approach to
study AMP interaction with membranes in order to obtain additional
and complimentary information to AMP activity studies and to
address the controversy surrounding the mechanism of action of
antimicrobial peptides. EIS [21] monitors the integrity of lipid
membranes in real time and is very sensitive to changes in
membrane properties such as membrane thickness, membrane
heterogeneity and ion permeation. We use a lipid bilayer with a
polyethylene glycol cushion supported on a silicon substrate as a
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by measuring changes in the bilayer impedance. Surface-supported
bilayers have been shown to preserve lateral mobility of lipids and
proteins in the bilayer, which is essential for the biomimetic
properties and the incorporation of many membrane proteins and
peptides [22]. Bilayer membranes formed by Langmuir–Blodgett (LB)
deposition on single crystal silicon have been shown to be excellent
electrochemical models of cell membranes [23]. In addition, this
biomimetic platform allows control over the composition of the
lipids in the bilayer as well as over the membrane potential. The
latter feature allows modulation of the activity of AMPs, but it is
difﬁcult to maintain a non-zero membrane potential when measure-
ments are carried out in liposomes. Here we measured the effect of
two antimicrobial peptides, selected from a combinatorial library
[24], on bilayer impedance. These antimicrobial peptides have very
similar sequences but show very different activity in vesicle leakage
assays [25], therefore they are particularly interesting for demon-
strating the feasibility and the sensitivity of the proposed approach
to study AMP activity. The results of EIS are compared with the
expected activity and are consistent with vesicle leakage assays. The
results can be interpreted within the framework of existing models of
AMP mode of action. In addition, EIS can reveal important new
details about AMP activity that are not accessible by other
experimental techniques, thus advancing the research in the ﬁeld
of antimicrobial peptides.
2. Materials and methods
2.1. Peptides
Two cationic peptides, each 26 residues long and sequentially
identical except for ﬁve combinatorially variable sites at positions 4, 5,
7, 20 and 23, were chosen from a library [24]. The peptides exhibit
similar antimicrobial activity but act differently in vesicle leakage
assay [25], therefore one is named a potent pore-former and the other
is a poor pore-former. The sequence of the potent pore-former is
RRGFSLKLALAKDGWALMLRLGYGRR (original library designation
FSKRGY [24]), and the sequence of the poor pore-former is
RRGAGLGLALAKDGWALMLKLGFGRR (AGGKGF). The peptides were
synthesized and puriﬁed by solid phase synthesis and high-perfor-
mance liquid chromatography, respectively [25].
2.2. Substrate
N-type silicon (111) wafers (Silicon Quest International, Inc., Santa
Clara, CA) with a thickness of 425–475 μm and a resistivity of 0.001–
0.005Ω cmwere used for all experiments. Thewafers were cleaned by
sequential immersion in 2-propanol (Fisher Scientiﬁc), acetone
(Pharmaco-Aaper), and 2-propanol, sonicating for 10 min in each
solvent, and stored in DI water at room temperature. Each wafer was
individually cleaned for 30 min in a fresh mixture of 30% hydrogenFig. 1. A surface-supported bilayer and its equivalent electrical circuit. The RsCs element corr
liquid charge transfer due to redox reaction and Cs being the double layer and the space cha
capacitance of the bilayer, and the series resistor Re corresponds to the resistance of the electr
measuring electrochemical impedance of the surface-supported bilayer.peroxide (Fisher Scientiﬁc) and 70% sulfuric acid (Fisher Scientiﬁc) and
rinsing 10 times with DI water.
2.3. Bilayer formation
Lipid bilayers were formed on the siliconwafers by ﬁrst depositing
Langmuir–Blodgett (LB) monolayer using a Langmuir trough (Model
611D, Nima Technology Ltd., Coventry, England), followed by vesicle
fusion. 1,2-diphytanoyl-sn-glycerol-3-phosphocholine (DPhPC) and
1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy
(polyethylene glycol)-2000] (PEG2k) were purchased from Avanti
Polar Lipids and used without further puriﬁcation. DPhPC provides
high membrane resistance while retaining membrane ﬂuidity, and is
therefore often used as the main lipid component in EIS experiments
[26,27]. Previous EIS characterization of melittin and gramicidin [27]
has utilized DPhPC, such that these results can be directly compared
with the results presented in the current study. DPhPC and PEG2k
were mixed at the crossover concentration [28], 94.1% to 5.9%, in
chloroform (Fisher Scientiﬁc) for a total lipid concentration of 1 mg/
ml. For vesicle preparation, DPhPC lipids dried from chloroform were
rehydrated with buffer (pH=7, 100 mM NaCl, 10 mM phosphate) for a
ﬁnal lipid concentration of 1 mg/ml. The lipid suspension was
extruded ten times using a mini-extruder (Avanti Polar Lipids,
Alabaster, AL) through a polycarbonate membrane with a pore
diameter of 100 nm (Whatman).
For each LB deposition, the silicon substrate was attached to the
dipping mechanism of the trough and lowered into the subphase,
18MΩ cmwater (Millipore, Bedford, MA). 20 μl of the chloroform lipid
solutionwas spread dropwise on the water surface of the open trough
(600 cm2), and the solvent was allowed to evaporate for 15 min. The
monolayer was then compressed at a speed of 100 cm2/min to a target
pressure of 42 mN/m, and the substrate was raised at 15 mm/min
while maintaining the target pressure.
The substrate, supporting the monolayer, was assembled into an
electrochemical half-cell. A small area of the oxide layer was removed
from the surface of the substrate outside the cell by carefully applying
25%hydroﬂuoric acidwith a cotton swab and a contact pointwasmade
with gallium–indium eutectic. The electrochemical cell was ﬁlled with
5ml buffer (pH=7,100mMKCl,10mMphosphate). The total area of the
bilayer in contact with the buffer was 0.8 cm2. Ag/AgCl (3 M KCl)
reference electrode was connected to the cell via a Luggin capillary.
The electrodes were connected to a computer-controlled lock-in
ampliﬁer (DSP-7265, Ametek, TN). A DC bias of 0 V was forced and
impedance spectrum measurements were started. Measurements
were taken at an AC perturbation of 20mVwith DC bias potentials 0 V,
0.5 V, and 1.0 V of Ag/AgCl, over the frequency range from 1 to 105 Hz,
with each scan lasting ∼1 min. After the ﬁrst scan was completed,
100 μl of vesicle solution was added using a gel-loading pipette tip
inserted through the hole in the platinum mesh counter-electrode,
∼2 mm beneath the platinum mesh. Change of electrochemical
impedancewith time during vesicle fusionwas observed and found toesponds to the support–electrolyte interface with the resistance Rs describing solid-to-
rge capacitance, while the RmCm (or RmCPE) element corresponds to the resistance and
olyte (buffer). The values of all electrical components are experimentally determined by
Fig. 2. AMP modes of action and corresponding changes in membrane parameters: resistance Rm and homogeneity n. Vertical dashed line in the graphs shows the moment of peptide
injection. If the peptides create a barrel-stave pore (A), themembrane becomesmore permeable to ions (Rm decreases), but themembrane thickness and homogeneity do not change. If the
peptides associate in a toroidal pore (B), themembrane also becomes leakier and themembrane thickness decreases along the pore perimeter resulting in a slightly decreasedhomogeneity.
If the peptides aggregate as in the carpetmodel (C), membrane homogeneity certainly decreaseswhilemembrane resistancemay decrease (in case the peptides introduce a disorder in the
lipids) or increase (in case the peptides have opposite, ordering effect [29]). In the detergent-like model (D) the peptides disrupt the membrane, resulting in a huge decrease or a complete
disappearanceofmembrane resistance. Themembrane can still provide anelectrochemical barrier if the disrupted regions canbe “repaired”by lateral lipid diffusion into those regions. One
may expect a decrease in homogeneity (lower n) due to the existence of different membrane regions: intact, disrupted, repaired. Overall, this disruption/repair process would result in a
decrease of lipid density and, as a consequence, decrease of membrane resistance Rm, and decrease of membrane thickness (higher Cm).
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proceed for 40 min before adding peptides. For experiments at
positive DC bias, the bias was changed from 0 V to the desired
potential and the system was allowed to re-equilibrate for another
20 min prior to adding peptides.
2.4. Peptide delivery
Both FSKRGY and AGGKGF were delivered in 0.1% acetic acid stock
solutionwith a peptide concentration ∼12 μM, which was determined
using tryptophan and tyrosine absorbance. The peptide solutions
were then added to the electrochemical cell via a gel-loading pipette
inserted ∼2 mm under the counter-electrode, using different volumes
to achieve desired peptide/lipid ratios. Previous high-throughput
screening assays [24,25] had determined 1/500 P/L as the lowest
concentrationwith observed pore-formation, and this was used as theminimum peptide concentration for experiments. Peptide/lipid ratios
were taken as the ratio between the number of peptide molecules and
the number of total lipidmolecules in the electrochemical cell, present
in both the tethered bilayer and in the free unfused vesicles in the
buffer. Experiments were also performed where free vesicles were
removed from the electrochemical cell by repeated removal and
replacement of the buffer.
Impedance measurements continued for 25 min after adding the
peptides. The addition of 0.1% acetic acid without peptides (in
negative control experiments) did not induce any detectable changes
in the impedance spectra.
2.5. Data analysis
The impedance data were analyzed using the complex nonlinear
least-squares immittance ﬁtting program (Zview, Scribner Associates).
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circuit with a resistor in series with a resistor–capacitor pair and a
resistor–constant phase element pair (see Fig. 1). Three components
were used for further analysis: the bilayer resistance Rm, the
capacitance term Q, and the exponent term n of the constant phase
element (CPE) (see the Theory section below).
3. Theory
A bilayer membrane in a moderate electrical ﬁeld can be modeled
as a capacitor in parallel with a resistance. For an ideal membrane
there is no ion transport across the bilayer (inﬁnite resistance) and the
membrane behaves like a dielectric medium with charge build up on
either side. Finite membrane resistance determines the rate of ion
diffusion through the bilayer. AMPs interacting with the membrane
affect both capacitance and resistance values. For example, membrane
thinning caused by AMPs would lead to an increase in the membrane
capacitance, which is given (per unit area) as:
Cm = e=d; ð1Þ
where ɛ and d are the permittivity and membrane thickness,
respectively. Similarly, ion channels or defects formed by AMPs
would lead to a decrease in the membrane resistance. The capacitance
and the resistance of the membrane can be directly measured by EIS,Fig. 3. Modulus, |Z| and phase angle, Θ, of the electrochemical impedance Z of surface-
supported bilayer versus frequency of applied oscillating voltage. DPhPC/PEG2k bilayer
(top panel). The measured points (ﬁlled circles) were ﬁtted to the response of the
electrical circuit shown in Fig. 1 using RC element for the membrane and yielding
Rs=10 MΩ cm2, Cs=2.1 μF/cm2, Rm=7.2 kΩ cm2, Cm=0.9 μF/cm2, Re=40 Ω cm2. Bilayer
after the addition of 1/100 P/L AGGKGF peptide (bottom panel). The measured points
were ﬁtted using CPE (see Fig. 1) yielding Rs=10 MΩ cm2, Cs=2.18 μF/cm2, Rm=4.9 kΩ
cm2, Q=4.35×10−6/cm2, n=0.84, Re=42Ω cm2. Note that the units of Q depend on n, see
Eq. (2). From these values we obtain Cm=0.87 μF/cm2 at 5 kHz, see Eq. (3).
Fig. 4. Resistance of DPhPC/PEG2K bilayer versus time at different peptide/lipid ratios
and DC potentials. FSKRGY (top panel) and AGGKGF (bottom panel) was added at
t=10 min at the peptide/lipid ratios and DC potentials indicated. The membrane
resistance drops within 1 min followed by minor equilibration over the next 3–10 min.
The presence of FSKRGY results in ∼5 times lower membrane resistance than the
presence of AGGKGF. There is no measurable dependence on membrane potential or
peptide concentration (in the range tested).thus revealing the effects of AMPs on the membrane. To allow
quantitative analysis of the membrane homogeneity we use a
constant phase element (CPE) as a more general representation of
membrane capacitance. The impedance of a CPE as a function of
angular frequency ω is given by
ZCPE ωð Þ = 1Q iωð Þn ð2Þ
where n is a measure of membrane homogeneity: the lower the n
value, the more heterogeneous the membrane is. When n=1, the
membrane is homogeneous and Q is equivalent to the membrane
capacitance. When n≠1, the membrane capacitance can be estimated
as
Cm ωð Þ =Q dωn−1 ð3Þ
and is frequency dependent; for nb1, Cm is higher at lower frequency.
This can be explained by the fact that thinner membrane regions
(regions with higher capacitance) have lower time constants and
therefore contribute more at low frequencies while membrane
thickest regions contribute at highest frequency.
Thus there are at least three electrical parameters describing the
membrane: (i) the membrane resistance Rm as a measure of
membrane “leakiness”, i.e. the degree of lipid order and the presence
Fig. 5. Membrane homogeneity n versus time at different peptide/lipid ratios and DC
potentials. FSKRGY (top panel) and AGGKGF (bottom panel) was added at t=10 min at
the peptide/lipid ratios and DC bias potentials indicated. For all DC bias potentials and
peptide concentrations, n decreased upon addition of FSKRGY. No such changes were
observed upon addition of AGGKGF. In FSKRGY experiments, more positive membrane
potentials resulted in more moderate changes; in addition, the changes were larger at
higher peptide concentration. Value of n reached minimum within 1–2 min, followed
by a partial relaxation with a time constant of about 8 min.
2434 W.K. Chang et al. / Biochimica et Biophysica Acta 1778 (2008) 2430–2436of ion channels or membrane defects, (ii) the exponent n as a measure
of membrane homogeneity, (iii) the membrane capacitance Cm as a
measure of membrane thickness. Fig. 2 shows four different AMP
modes of action [1–5] and anticipated electrochemical response.
4. Results
The impedance spectra of a DPhPC/PEG2k bilayer before and after
exposure to AGGKGF at a 1/100 P/L ratio are shown in Fig. 3. Prior to
peptide injection, the membrane is fairly homogeneous and can be
described by ideal capacitance Cm and resistance Rm, as shown in Fig.
3 (top panel); it is the action of AMPs which, depending on the mode
of action, render the membrane heterogeneous and lead to changes in
membrane thickness and “leakiness”. The use of the equivalent circuit
shown in Fig. 1 results in a good ﬁt to the measured impedance. Such
impedance spectra were taken every minute and the values for Rm, n
and Q, along with uncertainties from the ﬁt, were determined for each
spectrum.
Fig. 4 shows the membrane resistance versus time before and after
exposure to the peptides. The addition of either FSKRGY or AGGKGF
induces a signiﬁcant decrease in membrane resistancewithin 1min of
exposure to the bilayer. The ﬁnal value for the membrane resistance
Rm in the presence of FSKRGY is ∼1 kΩ cm2, while Rm ∼5 kΩ cm2 in
the presence of AGGKGF, a ﬁve fold difference. This shows that thepotent pore-former FSKRGY causes greater permeability of in the
membrane than the poor pore-former AGGKGF.
The effect of peptide addition on membrane homogeneity is
qualitatively different from the changes in membrane resistance:
while FSKRGY induces heterogeneity in the membrane with the
exponent n reaching minimum values of 0.70∼0.79 depending on
bias, the addition of AGGKGF causes no measurable effect on
membrane homogeneity (see Fig. 5). In the experiments with FSKRGY,
more positive membrane potentials result in less signiﬁcant changes.
In addition, the changes are smaller at lower peptide concentration.
Values of n reach minima within 1–2 min, followed by partial
relaxation (recovery) with a time constant of about 8 min.
Experiments were also performed where free vesicles were
removed from the electrochemical cell by repeated removal and
replacement of the buffer. Results from these experiments (not
shown) were similar to experiments with free vesicles present in
the buffer, but changes in homogeneity and its recovery were less
pronounced. Note that we used ∼10 times less peptides to keep the
same peptide/lipid ratio in vesicle-free experiments; therefore ﬁnal
bulk peptide concentration was much lower. Lower bulk concentra-
tion would result in lower peptide partitioning into the supported
membrane and to weaker overall effect.
As mentioned in the Theory section, the capacitance of a
heterogeneous membrane is frequency dependent. At 5 kHz, close
to the highest frequency at which Cm contributes to the measured
impedance, the membrane capacitance remains the same
(Cm=0.87 μF/cm2) before and after exposure to the peptides, even
when the membrane impedance exhibits large changes. This result
demonstrates that in all experiments the membrane thickness
remains the same in some regions while in other regions its thickness
decreases when membrane homogeneity decreases.
5. Discussion
The presented EIS data allow us to evaluate the range of possible
AMP modes of action. We have previously shown that channel-
forming peptides, such as gramicidin, change only membrane
resistance in a concentration-dependent fashion and do not change
the homogeneity and the capacitance of a surface-supported
membrane [23]. Purrucker et al. have shown that channel-forming
peptides do not change homogeneity of a surface-supported mem-
brane [30]. Similarly, addition of melittin, which acts according to the
barrel-stave model, to the bilayer leads to two orders of magnitude
drop in membrane resistance, while membrane capacitance and
homogeneity remain practically the same [27]. In contrast, we
observed a large decrease in membrane homogeneity in the presence
of the potent pore-former FSKRGY. Moreover, membrane resistance is
not dependent on peptide concentration within the range tested for
both the potent and poor pore-formers. Therefore, these AMPs do not
act according to the barrel-stave model.
For a toroidal pore model it is expected that the pore density
increases (lower membrane resistance) with higher peptide concen-
tration. No such trend was observed for both peptides. In addition, the
observed recovery of membrane homogeneity is not expected for the
toroidal pore model. If the toroidal pore acts like a gate for the
peptides to translocate to the other side of the membrane, the pores
themselves should be transient and disintegrate with time as the
concentration of the peptides on both sides of the membrane
equilibrates. The pore disintegration should lead to an increase in
membrane resistance, which was not observed.
According to the carpet model, peptides aggregate upon binding to
the bilayer, thus decreasing bilayer homogeneity and possibly
decreasing bilayer resistance. Therefore, the carpet model is consis-
tent with our experimental observations. However, the observed
recovery in membrane homogeneity in experiments with FSKRGY is
somewhat unexpected. After an initial minimum is reached, a
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experiments. It is therefore possible that carpet “rafts” formwithin the
ﬁrst minute, and that the observed recovery occurs after membrane
destabilization by the lateral redistribution of lipids/peptides. Since
the carpet model does not explicitly describe how and why rafts
destabilize the membrane, we cannot deﬁnitively rule out or support
this model using the impedance data. Nonetheless, we can conclude
that aggregation and membrane destabilization should occur within
the ﬁrst minute of the membrane exposure to the peptides, and that
such destabilization should be localized, since the overall membrane
remains intact and still exhibits a measurable resistance.
The observed decrease in homogeneity and membrane resistance
in FSKRGY experiments is also expected from the detergent model.
However, since the membrane remains intact and still exhibits
measurable resistance, the membrane disruption/dissolution occurs
locally and is consequently repaired by the lateral diffusion of lipids
into the damaged area, and there is no large scale membrane
disruption. Note that “healing” the disrupted regions by vesicle fusion
should inevitably decrease the ion permeability (increase the
membrane resistance), which was not observed. Therefore we have
to rule out the fusion of free vesicles as a possible recoverymechanism.
Thus the reparative behavior should be incorporated into the detergent
model to explain the observed recovery of membrane homogeneity.
There is another important consideration for both the carpet and the
detergent models. The constant value of the membrane capacitance Cm
at high frequency together with the observed decrease in homogeneity
implies that the membrane thickness stays the same in some regions
and gets thinner in the other regions after peptide interactions. Since
membrane thinning is expected upon interaction with AMP (see eg.
[31]), these local regions of decreased thickness are most likely the sites
of peptide interactions. The observed partial recovery towards a more
homogeneous membrane implies that, with time, the thinned regions
do equilibrate to some extent with the rest of the membrane. This
recovery is reminiscentof the recovery invesicle leakage assays: the rate
of efﬂux becomes smaller, with a time constant of a few minutes [9].
AGGKGF does not induce leakage in high-stringent assays
(1/500 P/L) while FSKRGY does [25] and both peptides exhibit
antimicrobial activity by sterilizing bacterial cultures at concentra-
tions of ∼2 μM whereas only AGGKGF had signiﬁcant cytotoxicity
and hemolytic activity against human cells [25]. We found that both
peptides reduce membrane resistance, which may be correlated with
antimicrobial activity. There are changes inmembrane resistance even at
high stringency, under conditions where AGGKGF should be inactive
according to the vesicle leakage assay. The reason for the observed
AGGKGF activity at high stringencymight be the fact that EIS is sensitive
to any ions that can leak through themembrane, while the leakage assay
detects the leakageof particular encapsulatedmolecules. Thus EISmaybe
more sensitive than the vesicle leakage assays to the membrane effects
that are important in antimicrobial activity. Note that some AMPs, like
dermaseptins, cecropin B, cecropin P and cecropin A dissipate ion
gradients at low peptide concentration, while much higher concentra-
tions are required to release encapsulated ﬂuorescent probe [32,33]. It is
possible that AGGKGF acts in a similar manner, which can explain the
potent sterilization activity of AGGKGF (via dissipation of ion gradient)
despite the poor vesicle leakage activity. AGGKGF may merely adhere/
intercalate into themembraneandcause lipid local disordering leading to
some ion leakage, thus decreasing membrane resistance. FSKRGY
peptides, in addition to the above-mentioned lipid disordering, aggregate
and disrupt the membrane, thus further decreasing the membrane
resistance. FSKRGY aggregates more strongly at higher concentration
(lower n at 1/100 P/L than at 1/500 P/L), as expected. In contrast to
FSKRGY, there is no change in homogeneity upon addition of AGGKGF.
This difference in peptide behavior correlates with lytic activity in
vesicles: AGGKGF does not cause vesicle leakage at high stringency,
whereas FSKRGYdoes. This suggests that lytic activity is a consequence of
peptide aggregation and of increase in membrane heterogeneity.It is well known that the activity of AMPs strongly depends on the
presence of negatively charged lipids in the target membrane. The bias
potential effectively sets the charge density of the tethered membrane
by means of ion accumulation on the membrane surface, thus
modulating the peptide partitioning into the membrane. Membrane
potentials affect the partitioning of peptides into membranes [34], as
well as the orientation and the degree of penetration of the peptides
within the membranes [35], consistent with our results. We observed
that the aggregation of FSKRGY depends on the membrane potential:
change in membrane potential from zero to a positive bias reduced
aggregation. Thus, the membrane potential is an additional parameter
that can be used to characterize and to modulate peptide activity. In
general, EIS on a surface-supported bilayer offers the unique possibility
to vary and maintain the membrane potential during peptide–
membrane interactions, which is often impossible to do in other assays.
The results reported here illustrate the general requirements for
studying AMP-membrane interaction using EIS. First, the surface-
supported membrane should be spatially homogeneous, that is the
lipids should form a continuous single phase without rafts. Second,
the membrane should be in the ﬂuid phase to provide lateral mobility
of membrane-associated peptides. Third, the membrane should be
decoupled from the solid support via a polymer cushion or spacer in
order to better accommodate possible peptide-induced lateral stress
or local membrane curvature. Finally, the ion permeability of the
membrane should be low to maximize the range for detection of AMP
interactions. Low ion permeability can be achieved when lipids are
densely packed and well ordered; the addition of cholesterol to low-
density disordered lipids can improve membrane resistance.
6. Conclusions
Using impedance spectroscopy, we characterized the mode of
action of two AMPs, a pore-former and a non pore-former [24,25]. Our
observations of the electrochemical response of membranes in the
presence of these AMPs support the carpet or detergent model for
AMPmode of actionwith the new ﬁndings: (i) membrane destabiliza-
tion occurs within the ﬁrst minute of membrane exposure to AMPs;
(ii) disruption/dissolution of the membrane occurs locally and is
consequently repaired, without leaving large patches of dissolved
membrane; (iii) recovery occurs after membrane destabilization,
either by the re-equilibration of lipids/peptides to achieve amore even
distribution (within the framework of the carpet model), or by lipid
lateral diffusion from the intact regions into the dissolved ﬂaws
(within the framework of the detergent model); (iv) after exposure to
the peptides, the membrane thickness in some regions remains the
same, in other regions (the sites of peptide interactions) it is reduced.
We have conﬁrmed that FSKRGY has signiﬁcantly more potent
membrane-disrupting activity than AGGKGF, supporting results of
previous vesicle leakage assay [25]. On the other hand, both peptides
increase the ion permeability of the membrane, supporting the results
of bacterial sterilization assay [25]. Positive membrane potentials
decrease FSKRGY ability to aggregate and to disrupt the membrane,
which is consistent with the notion that negative membrane charges
are important for AMP activity.
We have demonstrated that EIS can be used to characterize and
differentiate the activity of AMPs. This approach can be utilized to
study the inﬂuence of any antimicrobial peptide on membrane ion
permeability and heterogeneity. This information can, in turn, be used
to distinguish peptides by their modes of action and to assess their
potency in membrane destabilization.
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